III. Design, synthesis and study of a compound with potential trypanocidal activity;III. Diseño, síntesis y estudio de un compuesto con posible actividad tripanosomicida

Gaceta Medica de Mexico

Volumn 143, Issue 1, 2007, Pages 39-43

  Aguirre Alvarado, Charmina ^a   Zaragoza Martínez, Fabiola ^a   Rodríguez Páez, Lorena ^a   Nogueda Torres, Benjamín ^a   Baeza Ramíreza, Isabel ^a   Wong Ramíreza, Carlos ^a,b  

^a INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Chagas' disease; Trypanocidal drugs

Indexed keywords

ALPHA HYDROXIACID DEHYDROGENASE; ANTITRYPANOSOMAL AGENT; ISOENZYME; N ISOPROPYL OXAMIC ACID; NIFURTIMOX; OXAMIC ACID;

CHAGAS DISEASE; CONFERENCE PAPER; DRUG ACTIVITY; DRUG DESIGN; DRUG RESEARCH; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; EPIMASTIGOTE; HEART MUSCLE; HUMAN; SKELETAL MUSCLE; TRYPANOSOMA CRUZI;

EID: 50849100741     PISSN: 00163813     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. World Health Organization. Chagas disease special program for research and training in tropical diseases. 1993, pp 67-75.
2. World Health Organization. Control of Chagas disease. Tech Rep Ser. 2002;905:1-109.
3. Urbina JA. Parasitological cure of Chagas disease: is it possible? Is it relevant? Mem Inst Oswaldo Cruz 1999;94:349-355.
4. Coura RJ, De Castro S. A critical review on Chagas disease. Chemotherapy 2002;97:3-24.
5. Opperdoes FR. Biochemical peculiarities of trypanosomes, African and South American. Br Med Bull 1985;41:130-136.
6. Bakker BM, Westerhoff HV, Opperdoes FR, Michels PAM. Methabolic control analysis of glycolysis in trypanosomes as an approach to improve selectivity and effectiveness of drugs. Mol Biochem Pharmacol 2000;106:1-10.
7. Verlinde CL, Hannaert V, Blonski C, WiIIson M, Perie JJ, Fothergill-Gilmore lA, et al. Glycolysis as a target for the design of new antitrypanosome drugs. Drug Resist Update 2001;41:130-136.
8. Coronel CE, Roval LE, Gerez-de Burgos NM, Burgos C, Blanco A. Properties of a-hydroxyacid dehydrogenase isozymes from Trypanosoma cruzi. Mol Biochem Parasitol 1981;4:29-38.
9. Coronel C, Gerez-de Burgos NM, Burdos C, Blanco A. Separación y propiedades catalíticas de las izo enzimas de la a-hidroxiácido deshidrogenasa de Tripanosoma cruzi. Medicina (Buenos Aires) 1980; 40:159-164.
10. Montamat EE, Arauso SS, Blanco A. Subcellular localization of leucine aminotransferase and a-hydroxiacid dehydrogenase in Trypanosoma cruzi. Mol Biochem Parasitol 1987;22:185-93.
11. Gerez de Burgos NM, Burgos C, Montamat EE, Rovai LE, Blanco A. Inhibition by gossypol of oxidoreductases from Trypanosoma cruzi. Biochem Pharmacol 1984;33:955-959.
12. Elizondo S, Chena MA, Rodríguez-Paez L, Nogueda B, Baeza I, Wong C. Inhibition of Trypanosoma cruzi a-hydroxyacid dehydrogenase isozyme II by N-isopropyl oxamate and its effect on intact epimastigotes. J Enz Inhib Med Chem 2003;18:265-271.
13. Adunate J, Repeto V, Letelier M, Morillo A. The carboxyl esterases of Trypanosome cruzi epimastigotes. Comp Biochem Physiol 1987;86:67-71.
14. Chena M, Elizondo S, Rodríguez-Páez L, Nogueda B, Baeza I, Wong C. Trypanocidal activity of N-isopropyl oxamate on culture epimastigotes and murine trypanosomiasis using different Trypanosoma cruzi strains. J Enz Inhib Med Chem 2005;20:189-197.
15. Zaragoza M. Efecto tripanosomicida de tres ésteres etílicos de oxamatos N-substituidos, sobre estadios de Trypanosoma cruzi, presentes en huésped vertebrado. Tesis de Maestría ENCB-IPN, 2005.
16. Nogueda B. Desarrollo de inhibidores de oxidorreductasas de T. cruzi con posible actividad tripanosomicida. Tesis Doctoral ENCB-IPN, 1995.
17. Elizondo S. Estudio de inhibidores de la alfa hidroxiácido deshidrogenada de Tyipanosoma cruzi con posible actividad tripanosomicida. Tesis de Maestría ENCB-IPN, 1999.
18. Filardi L. Brener Z. Rapid method for testing in vivo the susceptibility of different strains of Trypanosoma cruzi to active chemotherapeutic agents. Mem Inst Oswaldo Cruz 1984;79:221-225.